1-54179265-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001031672.4(CYB5RL):c.628G>A(p.Glu210Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,613,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001031672.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYB5RL | NM_001031672.4 | c.628G>A | p.Glu210Lys | missense_variant | Exon 7 of 8 | ENST00000534324.6 | NP_001026842.2 | |
CYB5RL | NM_001353353.2 | c.391G>A | p.Glu131Lys | missense_variant | Exon 5 of 6 | NP_001340282.1 | ||
CYB5RL | NM_001353354.2 | c.184G>A | p.Glu62Lys | missense_variant | Exon 6 of 7 | NP_001340283.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYB5RL | ENST00000534324.6 | c.628G>A | p.Glu210Lys | missense_variant | Exon 7 of 8 | 5 | NM_001031672.4 | ENSP00000434343.1 | ||
ENSG00000256407 | ENST00000637610.1 | n.303+4896G>A | intron_variant | Intron 3 of 9 | 5 | ENSP00000490901.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461524Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727012
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.628G>A (p.E210K) alteration is located in exon 7 (coding exon 5) of the CYB5RL gene. This alteration results from a G to A substitution at nucleotide position 628, causing the glutamic acid (E) at amino acid position 210 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at